[
  {
    "ts": null,
    "headline": "Is Costco Stock Set to Rebound Higher in 2026?",
    "summary": "The company's dependable business model continues to deliver strong growth for shareholders. But its stock price remains difficult to justify.",
    "url": "https://finnhub.io/api/news?id=a13450827019b184c12234e5da14c3597faae6088b6aa3cc1aaa2c7a50bcecf1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767651900,
      "headline": "Is Costco Stock Set to Rebound Higher in 2026?",
      "id": 137997706,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "COST",
      "source": "Yahoo",
      "summary": "The company's dependable business model continues to deliver strong growth for shareholders. But its stock price remains difficult to justify.",
      "url": "https://finnhub.io/api/news?id=a13450827019b184c12234e5da14c3597faae6088b6aa3cc1aaa2c7a50bcecf1"
    }
  },
  {
    "ts": null,
    "headline": "Is Costco (COST) Pricing Too High After Recent Share Price Weakness?",
    "summary": "If you are wondering whether Costco Wholesale's share price really reflects what the business is worth, you are not alone. This article is here to unpack that question in a clear, practical way. The stock recently closed at US$854.50, with returns of a 1.5% decline over the past 7 days, a 4.5% decline over 30 days, flat performance year to date, and a 6.9% decline over 1 year, against a backdrop of an 86.0% return over 3 years and a 148.1% return over 5 years. Recent coverage around Costco...",
    "url": "https://finnhub.io/api/news?id=ee50be7c356d3b085e46e5076f375b6df659f5219ebcf6474df40e3f75a49c4a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767651076,
      "headline": "Is Costco (COST) Pricing Too High After Recent Share Price Weakness?",
      "id": 137997707,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "COST",
      "source": "Yahoo",
      "summary": "If you are wondering whether Costco Wholesale's share price really reflects what the business is worth, you are not alone. This article is here to unpack that question in a clear, practical way. The stock recently closed at US$854.50, with returns of a 1.5% decline over the past 7 days, a 4.5% decline over 30 days, flat performance year to date, and a 6.9% decline over 1 year, against a backdrop of an 86.0% return over 3 years and a 148.1% return over 5 years. Recent coverage around Costco...",
      "url": "https://finnhub.io/api/news?id=ee50be7c356d3b085e46e5076f375b6df659f5219ebcf6474df40e3f75a49c4a"
    }
  },
  {
    "ts": null,
    "headline": "5 Things Costco Needs to Do to End Its Stock Slump",
    "summary": "Costco Wholesale had a tough 2025, but the Wall Street favorite can get back on track this year—it just needs a catalyst or two to give it a jump start.  Costco  stock fell a little over 5% in 2025, while the  gained about 17%.  As Barron’s previously noted, the retailer was plagued by slower growth in foot traffic, higher tariffs, a lofty valuation, a dip in membership renewal rates, and tough compares from strong gold bar and gift card sales.",
    "url": "https://finnhub.io/api/news?id=ba2eadb3b55dbb644badbb7b93a7a1569b0e53c6a1009767be60fe5ea0e24ac8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767641520,
      "headline": "5 Things Costco Needs to Do to End Its Stock Slump",
      "id": 137997708,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "COST",
      "source": "Yahoo",
      "summary": "Costco Wholesale had a tough 2025, but the Wall Street favorite can get back on track this year—it just needs a catalyst or two to give it a jump start.  Costco  stock fell a little over 5% in 2025, while the  gained about 17%.  As Barron’s previously noted, the retailer was plagued by slower growth in foot traffic, higher tariffs, a lofty valuation, a dip in membership renewal rates, and tough compares from strong gold bar and gift card sales.",
      "url": "https://finnhub.io/api/news?id=ba2eadb3b55dbb644badbb7b93a7a1569b0e53c6a1009767be60fe5ea0e24ac8"
    }
  },
  {
    "ts": null,
    "headline": "This Exclusive Costco Perk Is Also Boosting Company Sales",
    "summary": "Costco performed very well throughout its 2025 fiscal year, but one change it offered some of its customer base was particularly effective.",
    "url": "https://finnhub.io/api/news?id=95d924c6e526aca085666b4366b8f1d5d3ac30573e4baaea64bf8e75f4f0c794",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767641400,
      "headline": "This Exclusive Costco Perk Is Also Boosting Company Sales",
      "id": 137997709,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "COST",
      "source": "Yahoo",
      "summary": "Costco performed very well throughout its 2025 fiscal year, but one change it offered some of its customer base was particularly effective.",
      "url": "https://finnhub.io/api/news?id=95d924c6e526aca085666b4366b8f1d5d3ac30573e4baaea64bf8e75f4f0c794"
    }
  },
  {
    "ts": null,
    "headline": "Tuesday's big stock stories: What’s likely to move the market in the next trading session",
    "summary": "The Dow Industrials touched an all-time high and closed at a record Monday after the U.S. captured Venezuela's president over the weekend.",
    "url": "https://finnhub.io/api/news?id=f61c6a26cf5f64df9f3ec20ba5d7ce27364cfa8830aeb0ac94abd8d0161590fa",
    "source": "CNBC",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767641062,
      "headline": "Tuesday's big stock stories: What’s likely to move the market in the next trading session",
      "id": 138001504,
      "image": "https://image.cnbcfm.com/api/v1/image/108234595-1764612176675-gettyimages-2236344491-COSTCO_EARNS.jpeg?v=1764612277&w=1920&h=1080",
      "related": "COST",
      "source": "CNBC",
      "summary": "The Dow Industrials touched an all-time high and closed at a record Monday after the U.S. captured Venezuela's president over the weekend.",
      "url": "https://finnhub.io/api/news?id=f61c6a26cf5f64df9f3ec20ba5d7ce27364cfa8830aeb0ac94abd8d0161590fa"
    }
  },
  {
    "ts": null,
    "headline": "Novo Nordisk Rolls Out Wegovy's Weight Loss Pill in US",
    "summary": "Novo Nordisk (NVO) said Monday that its Wegovy pill, the first oral medicine for obesity in the US,",
    "url": "https://finnhub.io/api/news?id=3a2a42854be48f78573d8907b87d6d08f5f340c5ac179a85fa3ac80f9bf79ba1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767640152,
      "headline": "Novo Nordisk Rolls Out Wegovy's Weight Loss Pill in US",
      "id": 137997666,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "COST",
      "source": "Yahoo",
      "summary": "Novo Nordisk (NVO) said Monday that its Wegovy pill, the first oral medicine for obesity in the US,",
      "url": "https://finnhub.io/api/news?id=3a2a42854be48f78573d8907b87d6d08f5f340c5ac179a85fa3ac80f9bf79ba1"
    }
  },
  {
    "ts": null,
    "headline": "5 2026 Market Predictions",
    "summary": "While 2026 will undoubtedly bring its own set of surprises, the combination of a dovish Fed, a maturing AI sector, and a resilient consumer suggests a year of significant expansion.",
    "url": "https://finnhub.io/api/news?id=b1ecb01f302c7a90287a15ed9ba6a6260322851355bf850d88d584d77cd5cea9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767638220,
      "headline": "5 2026 Market Predictions",
      "id": 137997566,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "COST",
      "source": "Yahoo",
      "summary": "While 2026 will undoubtedly bring its own set of surprises, the combination of a dovish Fed, a maturing AI sector, and a resilient consumer suggests a year of significant expansion.",
      "url": "https://finnhub.io/api/news?id=b1ecb01f302c7a90287a15ed9ba6a6260322851355bf850d88d584d77cd5cea9"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly Lags In The Weight-Loss Pill War. But It Has A Plan.",
    "summary": "Eli Lilly stock is falling as rival Novo Nordisk hit a milestone in the area of weight-loss drugs. But Lilly has a rival drug in the pipeline.",
    "url": "https://finnhub.io/api/news?id=3c4da6cbb3c82254c3586017832f3276757dc3d1893f474d202254eb65b3eea4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767636441,
      "headline": "Eli Lilly Lags In The Weight-Loss Pill War. But It Has A Plan.",
      "id": 137993616,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "COST",
      "source": "Yahoo",
      "summary": "Eli Lilly stock is falling as rival Novo Nordisk hit a milestone in the area of weight-loss drugs. But Lilly has a rival drug in the pipeline.",
      "url": "https://finnhub.io/api/news?id=3c4da6cbb3c82254c3586017832f3276757dc3d1893f474d202254eb65b3eea4"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly Lags In The Weight Loss Pill War. But It Has A Plan.",
    "summary": "Eli Lilly stock is falling as rival Novo Nordisk hit a milestone in the area of weight loss drugs. But Lilly has a rival drug in the pipeline.",
    "url": "https://finnhub.io/api/news?id=0f2b1925ceb1579c156372d041658982f1caddb7fb06e83310d9a22feb6f1827",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767636441,
      "headline": "Eli Lilly Lags In The Weight Loss Pill War. But It Has A Plan.",
      "id": 137993269,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "COST",
      "source": "Yahoo",
      "summary": "Eli Lilly stock is falling as rival Novo Nordisk hit a milestone in the area of weight loss drugs. But Lilly has a rival drug in the pipeline.",
      "url": "https://finnhub.io/api/news?id=0f2b1925ceb1579c156372d041658982f1caddb7fb06e83310d9a22feb6f1827"
    }
  },
  {
    "ts": null,
    "headline": "Final Trade: NVO, JPM, COST, MPC",
    "summary": "The final trades of the day with CNBC's Melissa Lee and the 'Fast Money' traders.",
    "url": "https://finnhub.io/api/news?id=8dc9e00de5d82ddcdef98cc5b0fd102c18e922f0e874019673222a7cabd7df26",
    "source": "CNBC",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767636149,
      "headline": "Final Trade: NVO, JPM, COST, MPC",
      "id": 138001506,
      "image": "https://image.cnbcfm.com/api/v1/image/108248512-17676540271767654025-43348875041-1080pnbcnews.jpg?v=1767654026&w=1920&h=1080",
      "related": "COST",
      "source": "CNBC",
      "summary": "The final trades of the day with CNBC's Melissa Lee and the 'Fast Money' traders.",
      "url": "https://finnhub.io/api/news?id=8dc9e00de5d82ddcdef98cc5b0fd102c18e922f0e874019673222a7cabd7df26"
    }
  },
  {
    "ts": null,
    "headline": "European Equities Mostly Higher in Monday Trading; Novo Nordisk Rolls Out Wegovy Pill in US",
    "summary": "European stock markets closed mostly higher in Monday trading with the Stoxx Europe adding 0.9%, Ger",
    "url": "https://finnhub.io/api/news?id=7c4dde94c620185b2ede65074b76437b77ae3c0aa773b5bb7893018ae69a0ea2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767632959,
      "headline": "European Equities Mostly Higher in Monday Trading; Novo Nordisk Rolls Out Wegovy Pill in US",
      "id": 137992489,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "COST",
      "source": "Yahoo",
      "summary": "European stock markets closed mostly higher in Monday trading with the Stoxx Europe adding 0.9%, Ger",
      "url": "https://finnhub.io/api/news?id=7c4dde94c620185b2ede65074b76437b77ae3c0aa773b5bb7893018ae69a0ea2"
    }
  },
  {
    "ts": null,
    "headline": "Costco fixes key member pain points (this time it's personal)",
    "summary": "Costco knows its members very well. That's how the chain keeps its overall item count low, but its sales for each item high. The chain has decades of data about what customers purchase and can use that to make sure its shelves have exactly what its members want. \"One of the secrets behind Costco’s ...",
    "url": "https://finnhub.io/api/news?id=4a1c6f7642616f9ef04897edc70b248962f005495585ae309519040b821a0089",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767632580,
      "headline": "Costco fixes key member pain points (this time it's personal)",
      "id": 137992417,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "COST",
      "source": "Yahoo",
      "summary": "Costco knows its members very well. That's how the chain keeps its overall item count low, but its sales for each item high. The chain has decades of data about what customers purchase and can use that to make sure its shelves have exactly what its members want. \"One of the secrets behind Costco’s ...",
      "url": "https://finnhub.io/api/news?id=4a1c6f7642616f9ef04897edc70b248962f005495585ae309519040b821a0089"
    }
  },
  {
    "ts": null,
    "headline": "Limitless X Appoints Seasoned Consumer Products and Manufacturing Executive Daniel Sanders as President",
    "summary": "LOS ANGELES, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Limitless X Holdings Inc. (OTCQX: LIMX), a diversified global consumer products, wellness, entertainment, and lifestyle company founded by entrepreneur Jas Mathur, today announced that its Board of Directors has appointed Daniel Sanders as President, effective immediately. Mr. Sanders brings over 20 years of senior executive experience across consumer nutraceuticals, wellness, product development, large-scale GMP manufacturing, and national retail d",
    "url": "https://finnhub.io/api/news?id=6fa50f93cbeb67854cd0ae07307aec942a49c0698ab9fc452081e5fdadf6f320",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767625200,
      "headline": "Limitless X Appoints Seasoned Consumer Products and Manufacturing Executive Daniel Sanders as President",
      "id": 137991046,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "COST",
      "source": "Yahoo",
      "summary": "LOS ANGELES, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Limitless X Holdings Inc. (OTCQX: LIMX), a diversified global consumer products, wellness, entertainment, and lifestyle company founded by entrepreneur Jas Mathur, today announced that its Board of Directors has appointed Daniel Sanders as President, effective immediately. Mr. Sanders brings over 20 years of senior executive experience across consumer nutraceuticals, wellness, product development, large-scale GMP manufacturing, and national retail d",
      "url": "https://finnhub.io/api/news?id=6fa50f93cbeb67854cd0ae07307aec942a49c0698ab9fc452081e5fdadf6f320"
    }
  },
  {
    "ts": null,
    "headline": "Novo Nordisk Stock Rises on Launch of Weight-Loss Pills",
    "summary": "Novo Nordisk’s shares rallied after the drugmaker said its new Wegovy weight-loss pill is now broadly available in the U.S., following regulatory approval last month.  The Wegovy product is the first GLP-1 pill approved specifically for weight loss.  It will tap into what analysts expect will be substantial demand from consumers seeking an alternative to the injections that have dominated the anti-obesity market to date.",
    "url": "https://finnhub.io/api/news?id=dffa7aade06eeb5490fe1e2917ff9d8e279e6822f7a378eb3abf08dad9ee2a31",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767625045,
      "headline": "Novo Nordisk Stock Rises on Launch of Weight-Loss Pills",
      "id": 137991006,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "COST",
      "source": "Yahoo",
      "summary": "Novo Nordisk’s shares rallied after the drugmaker said its new Wegovy weight-loss pill is now broadly available in the U.S., following regulatory approval last month.  The Wegovy product is the first GLP-1 pill approved specifically for weight loss.  It will tap into what analysts expect will be substantial demand from consumers seeking an alternative to the injections that have dominated the anti-obesity market to date.",
      "url": "https://finnhub.io/api/news?id=dffa7aade06eeb5490fe1e2917ff9d8e279e6822f7a378eb3abf08dad9ee2a31"
    }
  },
  {
    "ts": null,
    "headline": "PayPal downgraded, Costco upgraded: Wall Street's top analyst calls",
    "summary": "PayPal downgraded, Costco upgraded: Wall Street's top analyst calls",
    "url": "https://finnhub.io/api/news?id=5efd0026687d8caf141c9f0cde5b01e57cb13cd98c7ed71ee1f0e6ae4ed0f6b8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767624575,
      "headline": "PayPal downgraded, Costco upgraded: Wall Street's top analyst calls",
      "id": 137990794,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "COST",
      "source": "Yahoo",
      "summary": "PayPal downgraded, Costco upgraded: Wall Street's top analyst calls",
      "url": "https://finnhub.io/api/news?id=5efd0026687d8caf141c9f0cde5b01e57cb13cd98c7ed71ee1f0e6ae4ed0f6b8"
    }
  },
  {
    "ts": null,
    "headline": "Costco's Digital Ecosystem Emerges as a Powerful Growth Engine",
    "summary": "COST's digital push is paying off, with e-commerce, AI, and same-day delivery driving stronger member engagement and sales.",
    "url": "https://finnhub.io/api/news?id=dca5ff9e2cb5d8d13419b7302d2e9064efe4cd7302ebf3411243798237ac812a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767623640,
      "headline": "Costco's Digital Ecosystem Emerges as a Powerful Growth Engine",
      "id": 137991883,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "COST",
      "source": "Yahoo",
      "summary": "COST's digital push is paying off, with e-commerce, AI, and same-day delivery driving stronger member engagement and sales.",
      "url": "https://finnhub.io/api/news?id=dca5ff9e2cb5d8d13419b7302d2e9064efe4cd7302ebf3411243798237ac812a"
    }
  },
  {
    "ts": null,
    "headline": "Novo Nordisk’s Wegovy Pill Now Broadly Available Across U.S.",
    "summary": "Novo Nordisk’s Wegovy weight-loss pill is now broadly available across the U.S., two weeks after it received U.S. regulatory approval, the Danish drugmaker said.",
    "url": "https://finnhub.io/api/news?id=61433101f8fa8bd08dee976022d0f31a87c11bcfbf256baecfae6f168bee88d0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767620520,
      "headline": "Novo Nordisk’s Wegovy Pill Now Broadly Available Across U.S.",
      "id": 137991009,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "COST",
      "source": "Yahoo",
      "summary": "Novo Nordisk’s Wegovy weight-loss pill is now broadly available across the U.S., two weeks after it received U.S. regulatory approval, the Danish drugmaker said.",
      "url": "https://finnhub.io/api/news?id=61433101f8fa8bd08dee976022d0f31a87c11bcfbf256baecfae6f168bee88d0"
    }
  },
  {
    "ts": null,
    "headline": "Here's why Jim Cramer says Costco stock is starting to look attractive again",
    "summary": "\"I'm a short-term sufferer, long-term lover of Costco,\" Cramer said.",
    "url": "https://finnhub.io/api/news?id=1537ac82a95abefcff7172cdb4d40593945d70dd86b02f777076bf2cd8625efe",
    "source": "CNBC",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767620419,
      "headline": "Here's why Jim Cramer says Costco stock is starting to look attractive again",
      "id": 138001534,
      "image": "https://image.cnbcfm.com/api/v1/image/108235880-1764769316867-gettyimages-2249626383-dsc09542_copy_udkqsenp.jpeg?v=1767628726&w=1920&h=1080",
      "related": "COST",
      "source": "CNBC",
      "summary": "\"I'm a short-term sufferer, long-term lover of Costco,\" Cramer said. ",
      "url": "https://finnhub.io/api/news?id=1537ac82a95abefcff7172cdb4d40593945d70dd86b02f777076bf2cd8625efe"
    }
  },
  {
    "ts": null,
    "headline": "Novo Nordisk's Wegovy® pill, the first and only oral GLP-1 for weight loss in adults, now broadly available across America",
    "summary": "Wegovy® pill is now available, providing those seeking help with their weight the revolutionary science of GLP-1 medicine in a pill for the first time. This advancement opens new possibilities for the more than 100 million Americans living with obesity.2 Wegovy® pill was approved on December 22, 2025 and is used with a reduced calorie diet and increased physical activity for adults with obesity, or with overweight who also have weight-related medical problems, to help them lose weight and keep i",
    "url": "https://finnhub.io/api/news?id=55d21e127d264d62c57d70ed1c9424124d41ccd5002abb89d917edb7a9bd867e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767618000,
      "headline": "Novo Nordisk's Wegovy® pill, the first and only oral GLP-1 for weight loss in adults, now broadly available across America",
      "id": 137991073,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "COST",
      "source": "Yahoo",
      "summary": "Wegovy® pill is now available, providing those seeking help with their weight the revolutionary science of GLP-1 medicine in a pill for the first time. This advancement opens new possibilities for the more than 100 million Americans living with obesity.2 Wegovy® pill was approved on December 22, 2025 and is used with a reduced calorie diet and increased physical activity for adults with obesity, or with overweight who also have weight-related medical problems, to help them lose weight and keep i",
      "url": "https://finnhub.io/api/news?id=55d21e127d264d62c57d70ed1c9424124d41ccd5002abb89d917edb7a9bd867e"
    }
  },
  {
    "ts": null,
    "headline": "Costco stock rises on Mizuho upgrade, Top Pick designation",
    "summary": "Investing.com -- Costco stock rose around 1% in premarket trading Monday after Mizuho upgraded the retailer to Outperform and added it to its Top Picks list, arguing that recent concerns around slowing membership and comparable sales growth are overstated.",
    "url": "https://finnhub.io/api/news?id=c872234716f23f11e566bed68b453457d1be2659cbe58d30b3ed6d1716c82e96",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767614533,
      "headline": "Costco stock rises on Mizuho upgrade, Top Pick designation",
      "id": 137991075,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "COST",
      "source": "Yahoo",
      "summary": "Investing.com -- Costco stock rose around 1% in premarket trading Monday after Mizuho upgraded the retailer to Outperform and added it to its Top Picks list, arguing that recent concerns around slowing membership and comparable sales growth are overstated.",
      "url": "https://finnhub.io/api/news?id=c872234716f23f11e566bed68b453457d1be2659cbe58d30b3ed6d1716c82e96"
    }
  },
  {
    "ts": null,
    "headline": "Cramer’s Stop Trading: Costco",
    "summary": "CNBC’s Jim Cramer explains why he is keeping an eye on shares of Costco.",
    "url": "https://finnhub.io/api/news?id=b71cfaddd44080331087d829a0981599fd47e804eb44fe23ee01e0dde1ef29eb",
    "source": "CNBC",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767607468,
      "headline": "Cramer’s Stop Trading: Costco",
      "id": 137992691,
      "image": "https://image.cnbcfm.com/api/v1/image/108248141-17676250411767625039-43343009100-1080pnbcnews.jpg?v=1767625040&w=1920&h=1080",
      "related": "COST",
      "source": "CNBC",
      "summary": "CNBC’s Jim Cramer explains why he is keeping an eye on shares of Costco.",
      "url": "https://finnhub.io/api/news?id=b71cfaddd44080331087d829a0981599fd47e804eb44fe23ee01e0dde1ef29eb"
    }
  },
  {
    "ts": null,
    "headline": "First GLP-1 pill for obesity from Novo Nordisk launches in the U.S.",
    "summary": "The drug's cash prices are among the lowest on the market, ranging from $149 to $299 per month, depending on the dose.",
    "url": "https://finnhub.io/api/news?id=41d5018d51222f453ae6b6e610dcfa530288df891e6c290e9b55a713672adbc2",
    "source": "CNBC",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767600007,
      "headline": "First GLP-1 pill for obesity from Novo Nordisk launches in the U.S. ",
      "id": 137992675,
      "image": "https://image.cnbcfm.com/api/v1/image/108231180-17640121262025-11-24t185244z_352081195_rc263iank3kr_rtrmadp_0_novo-nordisk.jpeg?v=1765918401&w=1920&h=1080",
      "related": "COST",
      "source": "CNBC",
      "summary": "The drug's cash prices are among the lowest on the market, ranging from $149 to $299 per month, depending on the dose. ",
      "url": "https://finnhub.io/api/news?id=41d5018d51222f453ae6b6e610dcfa530288df891e6c290e9b55a713672adbc2"
    }
  },
  {
    "ts": null,
    "headline": "VIG: Proof That A Higher Yield Isn't Everything",
    "summary": "Vanguard Dividend Appreciation ETF (VIG) mixes dividend growth with favorable sectors. Read more about VIG here.",
    "url": "https://finnhub.io/api/news?id=1c161cf429298579cc1f69edda183ab767a637d65062d78afe362969dd6b2950",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767597300,
      "headline": "VIG: Proof That A Higher Yield Isn't Everything",
      "id": 137989894,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2231588505/image_2231588505.jpg?io=getty-c-w1536",
      "related": "COST",
      "source": "SeekingAlpha",
      "summary": "Vanguard Dividend Appreciation ETF (VIG) mixes dividend growth with favorable sectors. Read more about VIG here.",
      "url": "https://finnhub.io/api/news?id=1c161cf429298579cc1f69edda183ab767a637d65062d78afe362969dd6b2950"
    }
  },
  {
    "ts": null,
    "headline": "5 Things That Could Help Costco Stock Regain its Mojo",
    "summary": "Costco Wholesale had a tough 2025, but the Wall Street favorite can get back on track this year—it just needs a catalyst or two to give it a jump start.  Costco  stock fell a little over 5% in 2025, while the  gained about 17%.  As Barron’s previously noted, the retailer was plagued by slower growth in foot traffic, higher tariffs, a lofty valuation, a dip in membership renewal rates, and tough compares from strong gold bar and gift card sales.",
    "url": "https://finnhub.io/api/news?id=bc30b027867b0cd7f3db123af0901207e8d6f8954f3ac7dfa54281a6fd2bb6a0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767591000,
      "headline": "5 Things That Could Help Costco Stock Regain its Mojo",
      "id": 137991076,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "COST",
      "source": "Yahoo",
      "summary": "Costco Wholesale had a tough 2025, but the Wall Street favorite can get back on track this year—it just needs a catalyst or two to give it a jump start.  Costco  stock fell a little over 5% in 2025, while the  gained about 17%.  As Barron’s previously noted, the retailer was plagued by slower growth in foot traffic, higher tariffs, a lofty valuation, a dip in membership renewal rates, and tough compares from strong gold bar and gift card sales.",
      "url": "https://finnhub.io/api/news?id=bc30b027867b0cd7f3db123af0901207e8d6f8954f3ac7dfa54281a6fd2bb6a0"
    }
  }
]